Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|July 13, 2018
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinomaPriyanka C Iyer, Ramona Dadu, Maria Gule-Monroe, et al.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2021
Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid CarcinomaYu Qin, Jennifer R Wang, Ying Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|January 11, 2017
Patterns of Treatment Failure in Anaplastic Thyroid CarcinomaSarika N Rao, Mark Zafereo, Ramona Dadu, et al.
Endocrine|July 25, 2015
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosisLevent Ozsari, Merve Kutahyalioglu, Khaled M Elsayes, et al.
Journal of the Endocrine Society|February 22, 2019
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core PathwaysCallisia N Clarke, Panagiotis Katsonis, Teng-Kuei Hsu, et al.
Endocrine-Related Cancer|April 23, 2021
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patternsHa Nguyen, Komal Shah, Steven G Waguespack, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Molecular Cancer Therapeutics|October 31, 2013
Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAKHarina Vin, Grace Ching, Sandra S Ojeda, et al.
JAMA Oncology|October 24, 2024
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical TrialMaria E Cabanillas, Ramona Dadu, Renata Ferrarotto, et al.
Thyroid : Official Journal of the American Thyroid Association|June 6, 2022
Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF</i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter TrialNaifa L Busaidy, Bhavana Konda, Lai Wei, et al.
Pageof 11